De Novo Variants Disturbing the Transactivation Capacity of POU3F3 Cause a Characteristic Neurodevelopmental Disorder

American Journal of Human Genetics - United States
doi 10.1016/j.ajhg.2019.06.007
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

Elsevier BV

Related search

De Novo Variants in TAOK1 Cause Neurodevelopmental Disorders

American Journal of Human Genetics
Genetics
2019English

ZMIZ1 Variants Cause a Syndromic Neurodevelopmental Disorder

American Journal of Human Genetics
Genetics
2020English

ZMIZ1 Variants Cause a Syndromic Neurodevelopmental Disorder

American Journal of Human Genetics
Genetics
2019English

De Novo SOX4 Variants Cause a Neurodevelopmental Disease Associated With Mild Dysmorphism

American Journal of Human Genetics
Genetics
2019English

De Novo SOX4 Variants Cause a Neurodevelopmental Disease Associated With Mild Dysmorphism

American Journal of Human Genetics
Genetics
2019English

De Novo Mutations in SLC25A24 Cause a Disorder Characterized by Early Aging, Bone Dysplasia, Characteristic Face, and Early Demise

American Journal of Human Genetics
Genetics
2017English

Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy

American Journal of Human Genetics
Genetics
2019English

A De Novo Heterozygous Frameshift Mutation Identified in BCL11B Causes Neurodevelopmental Disorder by Whole Exome Sequencing

Molecular genetics & genomic medicine
GeneticsMolecular Biology
2019English

De Novo Truncating Variants in PHF21A Cause Intellectual Disability and Craniofacial Anomalies

European Journal of Human Genetics
Genetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy